HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An On-Demand Collaborative Innate-Adaptive Immune Response to Infection Treatment.

Abstract
Deep tissue infection is a common clinical issue and therapeutic difficulty caused by the disruption of the host antibacterial immune function, resulting in treatment failure and infection relapse. Intracellular pathogens are refractory to elimination and can manipulate host cell biology even after appropriate treatment, resulting in a locoregional immunosuppressive state that leads to an inadequate response to conventional anti-infective therapies. Here, we report a novel antibacterial strategy involving autogenous immunity using a biomimetic nanoparticle (NP)-based regulating system to induce in-situ collaborative innate-adaptive immune responses. We observed that a macrophage membrane coating facilitated NP enrichment at the infection site, followed by active NP accumulation in macrophages in a mannose-dependent manner. These NP-armed macrophages exhibited considerably improved innate capabilities, including more efficient intracellular ROS generation and pro-inflammatory factor secretion, M1 phenotype promotion, and effective eradication of invasive bacteria. Furthermore, the reprogrammed macrophages directed T cell activation at infectious sites, resulting in a robust adaptive antimicrobial immune response to ultimately achieve bacterial clearance and prevent infection relapse. Overall, these results provide a conceptual framework for a novel macrophage-based strategy for infection treatment via regulation of autogenous immunity. This article is protected by copyright. All rights reserved.
AuthorsLiang Chen, Zhenxuan Shao, Zengjie Zhang, Wangsiyuan Teng, Haochen Mou, Xiaoqiang Jin, Shenyu Wei, Zenan Wang, Yinwang Eloy, Wenkan Zhang, Hao Zhou, Minjun Yao, Shenzhi Zhao, Xupeng Chai, Fangqian Wang, Kaiwang Xu, Jianbin Xu, Zhaoming Ye
JournalAdvanced materials (Deerfield Beach, Fla.) (Adv Mater) Pg. e2304774 (Jul 31 2023) ISSN: 1521-4095 [Electronic] Germany
PMID37523329 (Publication Type: Journal Article)
CopyrightThis article is protected by copyright. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: